Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Stomach Neoplasms 135Pancreatic Neoplasms 36Esophageal Neoplasms 19Biliary Tract Neoplasms 19Colorectal Neoplasms 17Esophageal Squamous Cell Carcinoma 12Neoplasm Metastasis 10Cholangiocarcinoma 8Carcinoma, Non-Small-Cell Lung 7Gastrointestinal Neoplasms 6Nasopharyngeal Carcinoma 5Colonic Neoplasms 5Adenocarcinoma 5Recurrence 4Neoplasms 4Head and Neck Neoplasms 4Advanced Pancreatic Cancer 4Advanced Gastric Cancer 4Rectal Neoplasms 3Gastric Adenocarcinoma 3Gallbladder Neoplasms 3Advanced Solid Tumors 3Stage IV Gastric Cancer With Metastasis 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2NSCLC 2Locally Advanced Pancreatic Cancer 2Gastric Cancer Peritoneal Metastases 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2

Interventions

Fluorouracil 219Leucovorin 202Oxaliplatin 192Irinotecan 150Bevacizumab 110Capecitabine 94Cetuximab 90Folfox protocol 54Chemotherapy, Adjuvant 36Panitumumab 30Colonoscopy 30pembrolizumab 23Drug Therapy 23Nivolumab 22Magnetic Resonance Spectroscopy 22Gemcitabine 21Blood Specimen Collection 20Radiotherapy 19Floxuridine 19Biopsy 19Neoadjuvant Therapy 18Laparoscopy 18IFL protocol 18Early Intervention, Educational 18Celecoxib 18Surveys and Questionnaires 17Surgical Procedures, Operative 16Immunohistochemistry 16Exercise 16trifluridine tipiracil drug combination 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Colonic Neoplasms × S 1 (combination) × Clear all
NCT02216149 2018-08-28

FluoHeart

Helsinki University Central Hospital

Phase 2 Terminated
20 enrolled
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT02618356 2017-10-02

Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer

Fudan University

Phase 2 Unknown
82 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00660894 2016-08-03

Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Phase 3 Completed
1,535 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00569335 2012-11-02

Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer

Taiho Pharmaceutical Co., Ltd.

Phase 2 Completed
52 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00197431 2006-03-22

Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer

Hamamatsu University

Phase 2 Unknown
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡